http://ift.tt/eA8V8J
IRVINE, CA–(Marketwired – Jun 1, 2017) – Inolife Technologies Inc. (OTC PINK: INOL) (“Inolife” or the “Company”), an emerging leader in needle free injection devices, announced today that it has signed an agreement (the “Agreement”) with Maxim Group LLC (“Maxim Group”), a leading full-service investment banking, securities and wealth management firm headquartered in New York, to provide it with strategic corporate planning and investment banking services.
June 01, 2017 at 10:12PM
http://ift.tt/2qFVXio
from
http://ift.tt/2qFVXio